Literature DB >> 7876246

Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase.

W M Nauseef1, S J McCormick, R A Clark.   

Abstract

Myeloperoxidase (MPO), a lysosomal heme protein found exclusively in neutrophils and monocytes, is necessary for efficient oxygen-dependent microbicidal activity. Acquisition of heme by the heme-free MPO precursor apopro-MPO appears to be a prerequisite for its subsequent proteolytic processing and advancement along the biosynthetic pathway to mature MPO. We present data indicating that calreticulin (CRT), a high capacity calcium-binding protein residing in the lumen of the endoplasmic reticulum of a wide variety of cells, interacts specifically with fully glycosylated apopro-MPO. Biosynthetically radiolabeled CRT (60 kDa) and apopro-MPO (90 kDa) were coprecipitated from PLB 985 cells by monospecific antiserum against CRT when the immunoprecipitations were performed either under nondenaturing conditions or following reversible crosslinking. Nonglycosylated MPO precursors synthesized in the presence of tunicamycin did not interact with CRT. The CRT-apopro-MPO interaction was restricted to an early phase of MPO biosynthesis, and CRT did not interact with the later appearing, heme-containing species of MPO, i.e. pro-MPO or the heavy subunit of mature MPO. These data show that CRT participates in the post-translational processing of MPO, perhaps by maintaining apopro-MPO in a conformation competent to accommodate insertion of the heme group. In this general way, CRT shares certain functional properties with the structurally homologous transmembrane calcium-binding endoplasmic reticulum protein calnexin. Both interact with glycosylated biosynthetic precursors of proteins selectively expressed in specialized cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876246     DOI: 10.1074/jbc.270.9.4741

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  NMR structure of the calreticulin P-domain.

Authors:  L Ellgaard; R Riek; T Herrmann; P Güntert; D Braun; A Helenius; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  Expression of the high capacity calcium-binding domain of calreticulin increases bioavailable calcium stores in plants.

Authors:  Sarah E Wyatt; Pei-Lan Tsou; Dominique Robertson
Journal:  Transgenic Res       Date:  2002-02       Impact factor: 2.788

3.  Calreticulin inhibits glucocorticoid- but not cAMP-sensitive expression of tyrosine aminotransferase gene in cultured McA-RH7777 hepatocytes.

Authors:  K Burns; M Opas; M Michalak
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

4.  Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.

Authors:  Zhiwei Huang; Zhijia Fang; Hong Zhen; Li Zhou; Hesham M Amin; Ping Shi
Journal:  Leuk Lymphoma       Date:  2014-02-17

Review 5.  Biosynthesis of human myeloperoxidase.

Authors:  William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2018-02-03       Impact factor: 4.013

6.  Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins.

Authors:  A Choukhi; S Ung; C Wychowski; J Dubuisson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Induction of calreticulin expression in response to amino acid deprivation in Chinese hamster ovary cells.

Authors:  R Heal; J McGivan
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

8.  The structure of calreticulin C-terminal domain is modulated by physiological variations of calcium concentration.

Authors:  Ana María Villamil Giraldo; Máximo Lopez Medus; Mariano Gonzalez Lebrero; Rodrigo S Pagano; Carlos A Labriola; Lucas Landolfo; José M Delfino; Armando J Parodi; Julio J Caramelo
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

9.  Suppressive roles of calreticulin in prostate cancer growth and metastasis.

Authors:  Mahesh Alur; Minh M Nguyen; Scott E Eggener; Feng Jiang; Soheil S Dadras; Jeffrey Stern; Simon Kimm; Kim Roehl; James Kozlowski; Michael Pins; Marek Michalak; Rajiv Dhir; Zhou Wang
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

10.  Proconvertase proteolytic processing of an enzymatically active myeloperoxidase precursor.

Authors:  Sally McCormick; Angela Nelson; William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2012-08-10       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.